Tenofovir: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Tenofovir}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Category== | ==Category== | ||
==US Brand Names== | ==US Brand Names== | ||
| Line 14: | Line 12: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[ | ''' [[Tenofovir description|Description]]''' | ||
'''| [[ | '''| [[Tenofovir clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Tenofovir microbiology|Microbiology]]''' | ||
'''| [[ | '''| [[Tenofovir indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Tenofovir contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Tenofovir warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Tenofovir adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Tenofovir drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[Tenofovir overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Tenofovir clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[Tenofovir dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Tenofovir how supplied|How Supplied]]''' | ||
'''| [[ | '''| [[Tenofovir labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
==References== | ==References== | ||
Revision as of 15:07, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
US Brand Names
VIREAD®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages